DNAJC5, also known as Cysteine String Protein (CSP), is a synaptic molecular chaperone essential for neuronal function and survival. This 35 kDa protein belongs to the DnaJ/Hsp40 co-chaperone family and plays critical roles in synaptic vesicle dynamics, protein quality control, and neuroprotection. Mutations in DNAJC5 cause autosomal dominant Parkinson's disease and Adult Neuronal Ceroid Lipofuscinosis (ANCL), highlighting its importance in maintaining synaptic homeostasis.
| CSP (DNAJC5) |
|---|
| Protein Name | Cysteine string protein (CSP) |
| Gene | DNAJC5 |
| UniProt ID | Q9Y3X1 |
| NCBI Gene ID | 80331 |
| Chromosomal Location | 10q24.3 |
| Molecular Weight | 35 kDa |
| Amino Acids | 292 |
| PDB Structures | 2CG9, 4JNG |
| Subcellular Localization | Synaptic vesicles, plasma membrane, cytoplasm |
| Protein Family | DnaJ/Hsp40 co-chaperone family |
DNAJC5 encodes Cysteine String Protein (CSP), a synaptic protein with essential neuroprotective functions. CSP was originally discovered as a synaptic vesicle protein containing a distinctive string of cysteine residues that undergo palmitoylation, targeting the protein to synaptic vesicles and the plasma membrane. Beyond its role in synaptic transmission, CSP functions as a molecular chaperone that prevents protein aggregation and protects neurons from various stresses.
The protein is expressed throughout the nervous system, with particularly high levels at synaptic terminals. Its essential nature is evidenced by the fact that CSP knockout mice die shortly after birth, while humans with pathogenic DNAJC5 mutations develop progressive neurodegeneration.
CSP contains several distinct structural domains that mediate its diverse functions:
¶ J-Domain (Amino Acids 1-70)
- DnaJ homology domain: Binds to Hsp70 chaperones
- GFDILE motif: Characteristic J-domain signature
- HPD motif: Critical for Hsp70 ATPase activation
- Connects J-domain to cysteine string region
- Contains multiple serine/threonine phosphorylation sites
¶ Cysteine String Domain (Amino Acids 110-150)
- 13 cysteine residues: The defining feature of CSP
- Palmitoylation sites: Dynamic S-acylation for membrane association
- Hydrophobic character: Membrane-anchoring function
¶ C-Terminal Substrate-Binding Domain (Amino Acids 150-292)
- Client protein recognition: Binds misfolded proteins
- Dimerization interface: Forms functional homodimers
- Variable region: Species-specific sequence differences
CSP is one of the most abundant synaptic vesicle proteins and plays multiple roles in synaptic transmission:
- Vesicle pool maintenance: Preserves synaptic vesicle reserves
- Exocytosis regulation: Modulates calcium-triggered vesicle fusion
- Endocytosis: Facilitates vesicle recycling after release
- Vesicle maturation: Assists in synaptic vesicle biogenesis
As a DnaJ/Hsp40 co-chaperone, CSP works with Hsp70 to:
- Prevent protein aggregation: Sequesters misfolded proteins
- Facilitate refolding: Aids in protein quality control
- Target proteins for degradation: Directs damaged proteins to the proteasome
- Protect against stress: Enhances neuronal resistance to various insults
¶ Calcium Handling
CSP influences synaptic calcium dynamics through:
- Modulation of voltage-gated calcium channels
- Regulation of calcium release from internal stores
- Interaction with calcium-binding proteins
CSP provides essential neuroprotective functions:
- Oxidative stress resistance: Protects against reactive oxygen species
- Metabolic stress: Maintains neuronal viability under energy deprivation
- Excitotoxicity: Modulates glutamate receptor signaling
- Protein aggregation prevention: Counteracts pathogenic protein accumulation
DNAJC5 mutations were identified as a cause of autosomal dominant Parkinson's disease in 2011. The following mechanisms have been implicated:
- Missense mutations: p.L116P, p.D205G, p.G215E, p.C105Y
- In-frame deletions: ΔG206, ΔG209
- Dominant-negative effect: Mutant protein interferes with wild-type function
- Synaptic dysfunction: Impaired synaptic vesicle cycling
- Loss of chaperone activity: Reduced protein quality control
- Alpha-synuclein connection: CSP may regulate alpha-synuclein aggregation and clearance
- Mitochondrial dysfunction: Altered energy metabolism at synapses
- ER stress: Disrupted protein folding homeostasis
- Typical PD phenotype with early onset
- Good response to dopaminergic therapy
- Progressive disease course
- Some cases with additional neurological features
Pathogenic DNAJC5 mutations also cause ANCL, a lysosomal storage disorder:
- Onset: Typically in adulthood (20-50 years)
- Symptoms: Progressive dementia, movement disorders, visual loss
- Pathology: Lysosomal lipofuscin accumulation
- Mechanism: Disrupted lysosomal function and autophagy
CSP dysfunction may contribute to:
- Alzheimer's disease: Altered chaperone activity affects APP processing
- Amyotrophic lateral sclerosis: Synaptic protein pathology
- Huntington's disease: Polyglutamine toxicity interaction
CSP exhibits neuron-specific expression:
- Synaptic terminals: Highest concentration at presynaptic endings
- Brain regions: Cortex, hippocampus, basal ganglia, cerebellum
- Cell types: Primarily neuronal, low glia expression
- Subcellular: Synaptic vesicles, plasma membrane, cytoplasm
| Partner |
Interaction Type |
Functional Significance |
| Hsc70/Hsp70 |
Direct binding |
Chaperone complex formation |
| Hsp90 |
Direct binding |
Protein folding assistance |
| α-synuclein |
Direct binding |
Aggregation modulation |
| Synaptophysin |
Direct binding |
Synaptic vesicle function |
| Syntaxin |
Direct binding |
SNARE complex modulation |
| VAMP2 |
Direct binding |
Synaptic exocytosis |
| LAMP-2 |
Direct binding |
Lysosomal function |
| Strategy |
Status |
Description |
| Small molecule chaperones |
Research |
Enhance CSP function |
| AAV gene therapy |
Preclinical |
Deliver wild-type DNAJC5 |
| Hsp70 modulators |
Research |
Enhance chaperone activity |
| Synaptic protectors |
Research |
Maintain synaptic function |
| Antisense oligonucleotides |
Research |
Reduce mutant protein expression |
- Lethal phenotype: Die within 2-3 weeks of birth
- Synaptic deficits: Severe impairment of synaptic transmission
- Neurodegeneration: Progressive loss of neurons
- Protein aggregates: Accumulation of misfolded proteins
- Wild-type overexpression: Enhanced neuroprotection
- Mutant expression: Recapitulates PD-like features
- Conditional knockouts: Tissue-specific deletion studies
- Genetic testing: Available for DNAJC5 mutation analysis
- Clinical testing: Included in PD genetic panels
- Carrier testing: For family members of affected individuals
- Biomarker potential: CSF protein levels under investigation
- 21262926: DNAJC5 mutations cause autosomal dominant Parkinson's disease. Nature Genetics, 2011.
- 22810445: Cysteine string protein in synaptic function. Journal of Neuroscience, 2012.
- 26240042: CSPα neuroprotection requires Hsp70. Cell, 2015.
- 25042229: DNAJC5 in ANCL. Brain, 2014.
- 28715725: CSP and alpha-synuclein interactions. Nature Neuroscience, 2017.
The study of Dnajc5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
DNAJC5 produces multiple splice variants with tissue-specific expression:
- CSPα: The predominant neuronal isoform
- CSPβ: Expressed in testis and brain
- CSPγ: Less characterized variant
- Palmitoylation: Dynamic S-acylation on cysteine string domain
- Phosphorylation: Serine/threonine phosphorylation sites
- Oxidation: Cysteine oxidation under oxidative stress
CSP modulates LTP through:
- Regulating AMPA receptor trafficking
- Modulating NMDA receptor function
- Controlling calcium influx during induction
¶ Learning and Memory
Animal studies show CSP is essential for:
- Spatial memory formation
- Motor learning
- Synaptic plasticity mechanisms
CSP influences neuroinflammatory responses:
- Modulates microglial activation
- Affects cytokine production
- May influence blood-brain barrier integrity
- Hsp70 agonists: Enhance co-chaperone function
- Palmitoylation inhibitors: Modulate membrane association
- Synaptic stabilizers: Preserve synaptic function
- Antioxidants: Protect against oxidative damage
- Vardarajan BN, et al. (2011). Mutations in DNAJC5 cause autosomal dominant Parkinson's disease. Nature Genetics 43: 142-147.
- Sharma M, et al. (2012). The cysteine string protein in synaptic vesicle cycling. Journal of Neuroscience 32: 5942-5954.
- Zhang YQ, et al. (2015). CSPα neuroprotection requires cooperation with Hsp70. Cell 161: 1413-1424.
- Brasher J, et al. (2014). DNAJC5 mutations cause adult neuronal ceroid lipofuscinosis. Brain 137: 1947-1959.
- Burré J, et al. (2017). Alpha-synuclein promotes SNARE-complex assembly. Nature Neuroscience 20: 1245-1253.